文献速递其他结缔组织病血管炎

美国西南部白塞病特征研究

Characteristics of Behcet's Disease in the American Southwest.
PubMed 文献 · Semin Arthritis Rheum · 2019-03-09

该横断面研究分析了美国西南部63例符合ISG标准及76例符合ICBD标准的白塞病患者,估计患病率为8.9-10.6/10万。84.1%的患者最初被诊断为非白塞病,常见口腔阿弗他溃疡(100%)等表现,HLA-B51在美洲原住民和西班牙裔中更常见。羟氯喹使用频繁,可能为有效替代治疗。

要点

  • 美国西南部白塞病患病率估计为8.9-10.6/10万
  • 84.1%患者最初被误诊为非白塞病原发诊断
  • HLA-B51在美洲原住民(89.0%)和西班牙裔(74.2%)中更常见

核心结论

  • 白塞病在美国西南部常见,患病率为8.9-10.6/10万。
  • 白塞病患者常最初被诊断为其他原发疾病。
  • 羟氯喹可能是白塞病的有效替代治疗。

研究设计与样本

  • 横断面研究,为期2年临床 encounter 的白塞病患者。
  • 63例符合国际研究组标准(ISG),76例符合国际白塞病标准(ICBD)。

主要发现

  • 女性与男性比例为4.7:1。
  • 84.1%(53/63)最初诊断为非白塞病原发诊断,包括炎性关节炎(15.9%)、纤维肌痛(7.9%)、血管炎(7.9%)或系统性红斑狼疮(7.9%)。
  • 常见表现:口腔阿弗他溃疡(100%)、痤疮样病变(69.8%)、生殖器阿弗他溃疡(61.9%)、丘疹脓疱性病变(52.4%)、假性毛囊炎(42.9%)、炎性关节炎(41.3%)、前葡萄膜炎(23.8%)、后葡萄膜炎(15.9%)、针刺反应(15.9%)、深静脉血栓(14.3%)、非眼部血管炎(11.1%)、结节性红斑(7.9%)、动脉血栓(6.3%)、视网膜血管炎(1.6%)。
  • 民族比例:西班牙裔美国人49.2%、欧洲裔美国人31.7%、美洲原住民14.3%、丝绸之路1.7%。
  • HLA-B51阳性率:美洲原住民89.0%(p=0.02)、西班牙裔74.2%(p=0.02)高于欧洲裔42.1%。

关键数值与推荐

  • 白塞病诊断采用ISG或ICBD标准。
  • 估计患病率为8.9-10.6/10万。
  • HLA-B51在美洲原住民中阳性率89.0%(p=0.02),西班牙裔74.2%(p=0.02),欧洲裔42.1%。

临床怎么用

  • 临床遇到疑似白塞病患者时应考虑进行详细评估,避免误诊为炎性关节炎、纤维肌痛、血管炎或系统性红斑狼疮。
  • 在西班牙裔和美洲原住民人群中,HLA-B51检测可能有助于支持诊断。
  • 羟氯喹可作为白塞病的替代治疗选择。

局限性

  • 横断面研究设计,无法确定因果关系。
  • 样本量有限,来自单一地区。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The goal of this study was to determine the characteristics of Behçet's disease (BD) in the American Southwest. MATERIAL AND METHODS: This was a cross-sectional study of BD patients clinically encountered during a 2-year period. All subjects fulfilled the International Study Group criteria (ISG) or International Criteria for Behcet's Disease (ICBD). Age, gender, clinical characteristics, substance use, and HLA-B51 status were determined. RESULTS: 63 patients (female: male ratio: 4.7:1) fulfilled ISG criteria and 76 the ICBD criteria (estimated prevalence of 8.9-10.6 per 100,000). 84.1% (53/63) were initially diagnosed with non-BD primary diagnoses including inflammatory arthritis (15.9%), fibromyalgia (7.9%), vasculitis (7.9%), or systemic lupus erythematosus (7.9%). Common BD manifestations were oral aphthous ulcers (100%), acneiform lesions (69.8%), genital aphthous ulcers (61.9%), papulopustular lesions (52.4%), pseudofolliculitis (42.9%), inflammatory arthritis (41.3%), anterior uveitis (23.8%), posterior uveitis (15.9%), pathergy (15.9%), deep vein thrombosis (14.3%), non-ocular vasculitis (11.1%), erythema nodosum (7.9%), arterial thrombosis (6.3%), and retinal vasculitis (1.6%). BD ethnic proportions were 49.2% Hispanic American (HA), 31.7% European-American (EA), 14.3% Native American (NA), and 1.7% Silk Road. HLA-B51 was present more in NA (89.0%, p = 0.02) and HA (74.2%, p = 0.02) compared to EA (42.1%). Therapy of BD was conventional, except for the frequent use of hydroxychloroquine. CONCLUSIONS: BD is common in the American Southwest with a prevalence of 8.9-10.6 cases per 100,000. BD patients are commonly initially diagnosed with alternative primary conditions. Hydroxychloroquine may be an effective alternative therapy for BD. This is one of the first reports of BD in HA and NA populations.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Muruganandam M, Rolle NA, Sibbitt WL, et al. Characteristics of Behcet's Disease in the American Southwest. Semin Arthritis Rheum. 2019. PMID: 30952423. doi:10.1016/j.semarthrit.2019.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。